The Quarter story
The two most recent quarterly results, compared side-by-side.
Insecticides India Ltd shows a strong seasonal rebound in Q1 FY27, with profits and margins recovering after a weak mid-year period.
Revenue from operations recovers from ₹384.92 Cr in Q3 FY26 to ₹611.52 Cr in Q1 FY27 — seasonal demand drives sales back to normal levels.
B2C sales mix contracts from 77% in Q2 FY26 to 64% in Q1 FY27 — retail channel share shrinks as the company pivots to B2B.
EBITDA margin rebounds from 6.0% in Q4 FY26 to 11.1% in Q1 FY27 — pricing power and cost control stabilize profitability.
Export sales mix falls from 6% in Q3 FY26 to 2% in Q1 FY27 — overseas revenue contribution declines.
B2B sales mix expands from 17% in Q3 FY26 to 34% in Q1 FY27 — institutional buyers take a larger share of total sales.
Employee expenses rise from ₹37.99 Cr in Q4 FY26 to ₹47.34 Cr in Q1 FY27 — staffing costs climb in line with hiring cycles.
Gross profit climbs from ₹128.87 Cr in Q4 FY26 to ₹193.16 Cr in Q1 FY27 — stronger product demand lifts top-line margins.
Other expenses increase from ₹65.28 Cr in Q4 FY26 to ₹78.22 Cr in Q1 FY27 — variable operational spending tracks higher.
PAT margin recovers from 2.7% in Q4 FY26 to 7.2% in Q1 FY27 — bottom-line earnings normalize after a weak mid-year period.
Finance cost moves from ₹3.72 Cr in Q1 FY26 to ₹4.69 Cr in Q1 FY27 — debt servicing charges remain elevated.
NSE
BSE
